The FDA granted 510(k) clearance for Aesku’s automated vasculitis test, the Helios automated immunofluorescence assay system.

The sample-in/sample-out platform processes and analyzes patient samples in a single run and uses an integrated design and pattern recognition software.

The automated assay can be used to distinguish between adeno-associated viruses and infection.